By David Merchant WASHINGTON–(BUSINESS WIRE)–Today, Citizens for Responsibility and Ethics in Washington (CREW), the National Legislative Association on Prescription Drug Prices (NLARx), the Campaign for America’s Future (CAF), and the U.S. Public Interest Research Group (U.S. PIRG) called on the Federal Trade Commission (FTC) to immediately investigate the vaccine bundling practices of Sanofi Pasteur and Merck, which […]
Doctor Alleges Monopoly on Vaccine
By Cheryl Armstrong, Courthouse News Service NEWARK (CN) – In an antitrust class action, a doctor says Sanofi Pasteur, the world’s largest producer of vaccines, uses its monopoly on meningococcal vaccines in the United States to raise prices and crush competition. Sanofi has “an overwhelming 93 percent market share” of the meningococcal vaccine market in […]
Sanofi Pasteur Acquires Exclusive, Worldwide License for Acne Vaccine and Treatment
Fierce Biotech Posted September 21, 2011 Sanofi Pasteur Acquires Exclusive, Worldwide License for Acne Vaccine and Treatment- The pre-clinical vaccine was developed by researchers at the University of California, San Diego – Lyon, France – September 21, 2011 – Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today a research […]
Hospitalized girls prompt Gardasil recall
Fierce Pharma February 11, 2009 — 11:41am ET | By Tracy Staton A bolt out of the blue for Merck’s Gardasil, with two 14-year-old girls in Spain hospitalized after receiving the human papillomavirus vaccine. Health authorities in Spain have now withdrawn an entire batch–nearly 76,000 doses–of the shot. Both girls developed convulsions and at least […]
Merck Sharpe and Dohme and Sanofi Pasteur begin new vaccine trial
Posted on 26/04/2011 in Pharmaceutical Company Product News Merck Sharpe and Dohme and its partner Sanofi Pasteur have commenced a clinical study of a new vaccine designed to treat a range of diseases among children. The companies have begun a phase III study of the hexavalent combination vaccine that will test the safety and immunogenicity […]
